Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Therapeutic BCG Vaccines Global Market Report 2025
Request Sample Buy Now
Global Therapeutic BCG Vaccines Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Therapeutic BCG Vaccines Global Market Report 2025

By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Therapeutic BCG Vaccines Market Overview

• Therapeutic BCG Vaccines market size has reached to $56.47 billion in 2024

• Expected to grow to $75.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Fighting Tuberculosis Surging Global Cases Propel Growth In The Therapeutic Bcg Vaccine Market

• Market Trend: ImmunityBio And Serum Institute Of India Strategic Partnership To Advance Therapeutic Bcg Vaccine Development

• Asia-Pacific was the largest region in 2024.

What Is Covered Under Therapeutic BCG Vaccines Market?

Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.

The major types of therapeutic BCG vaccines are therapy BCG and immune BCG. Therapy BCG refers to a kind of intravesical immunotherapy that aids the immune system's destruction of cancer cells and is frequently used to treat bladder cancer in its early stages. By demographics, BCG vaccines can be used on pediatrics and adults. These are used by several end-users, such as hospitals, clinics, and other end-users.

Therapeutic BCG Vaccines Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Therapeutic BCG Vaccines Market Size 2025 And Growth Rate?

The therapeutic bcg vaccines market size has grown strongly in recent years. It will grow from $56.47 billion in 2024 to $59.09 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains.

What Is The Therapeutic BCG Vaccines Market Growth Forecast?

The therapeutic bcg vaccines market size is expected to see strong growth in the next few years. It will grow to $75.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches.

The forecast of 6.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade disputes may disrupt bladder cancer immunotherapy by increasing costs of bacillus calmette-guérin vaccine strains cultivated in Japan and Denmark, potentially reducing non-muscle invasive bladder cancer treatment availability and raising urologic oncology expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Therapeutic BCG Vaccines Market Segmented?

1) By Type: Therapy BCG, Immune BCG

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

Subsegments:

1) By Therapy BCG: Intravesical BCG, Injectable BCG

2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment

What Is Driving The Therapeutic BCG Vaccines Market? Fighting Tuberculosis Surging Global Cases Propel Growth In The Therapeutic Bcg Vaccine Market

The rising number of tuberculosis (TB) cases worldwide will propel the growth of the therapeutic BCG vaccine market going forward. Tuberculosis (TB) is an infectious illness that can be potentially dangerous and primarily impacts the lungs. People can contract tuberculosis from one another by coughing or sneezing small droplets of bacteria into the air. BCG vaccines are used to stimulate the immune system to fight infection but do not cause TB since the germs are weak. It consistently offers protection against the most dangerous types of TB, such as adolescent TB meningitis. The BCG vaccine protects against tuberculosis which helps to fight against infection, hence the usage of therapeutic BCG vaccines increased. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the rising number of tuberculosis (TB) cases worldwide is driving the growth of the therapeutic BCG vaccine industry.

What Is Driving The Therapeutic BCG Vaccines Market? Therapeutic BCG Vaccines Rise To The Challenge Amidst Growing Drug-Resistant Tuberculosis Incidence

The rising incidence of drug-resistant TB cases is expected to propel the growth of the therapeutic BCG vaccine market in the coming years. Drug-resistant tuberculosis (TB) is a kind of tuberculosis in which the bacteria responsible for the disease, Mycobacterium tuberculosis, acquire resistance to the medications routinely used to treat the infection. Therapeutic Bacillus Calmette-Guérin (BCG) vaccines, while primarily known for their use in preventing certain forms of tuberculosis (TB), have also been explored in the context of drug-resistant tuberculosis (DR-TB). For instance, in November 2023, according to the Centers for Disease Control and Prevention, a US-based federal agency that works for the Department of Health and Human Services, resistance to at least isoniazid was recorded in 528 (8.4%) of TB cases in the United States in 2022, including 90 (1.4%) multidrug resistance cases. Among those born in the United States, 86 (5.7%) had INH-resistant TB, with 11 (0.7%) having MDR TB. Therefore, the rising incidence of drug-resistant TB cases is driving the therapeutic BCG vaccine industry.

Who Are The Major Players In The Global Therapeutic BCG Vaccines Market?

Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan

What Are The Key Trends Of The Global Therapeutic BCG Vaccines Market? ImmunityBio And Serum Institute Of India Strategic Partnership To Advance Therapeutic Bcg Vaccine Development

Strategic partnerships have emerged as a key trend gaining popularity in the therapeutic BCG vaccine market. Major companies operating in the therapeutic BCG vaccine market are focused on collaborating with other key players to sustain their position in the market. For instance, in May 2024, ImmunityBio, a US-based biotechnology company, partnered with Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, to secure a supply of the Bacillus Calmette-Guerin (BCG) vaccine for all cancer types. The partnership focuses on producing the standard BCG (sBCG) approved for use outside the US and a next-generation recombinant BCG (iBCG) currently undergoing tests. iBCG is intended for use along with ImmunityBio’s ANKTIVA (nogapendekin alfa inbakicept-PMLN) for approved and additional future indications, contingent on regulatory approvals.

What Are The Key Trends Of The Global Therapeutic BCG Vaccines Market? Innovative Therapeutic Applications Of Bcg Immunotherapy

Major companies operating in the therapeutic BCG vaccine market are focused on innovating vaccines for potential therapeutic applications in various medical conditions, such as BCG immunotherapy, to expand their customer base and meet growing patient needs. BCG (Bacillus Calmette-Guérin) immunotherapy refers to the use of the BCG vaccine as a form of immunotherapy to treat certain types of cancer, particularly bladder cancer. For instance, in July 2023, The Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, received government approval to export its BCG vaccine to Canada for immunotherapeutic use in treating bladder cancer. This live freeze-dried preparation, derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is intended for intravenous instillation. The vaccine is available in 40 mg and 80 mg presentations. As an integral part of the therapy, the vaccine is administered directly into the bladder through a catheter, where it remains in the bladder lining for a specified duration. This targeted approach aims to impact cancer cells effectively while minimizing impact on other parts of the body.

Need data on a specific region in this market?
Request Customisation

Therapeutic BCG Vaccines Market Merger And Acquisition: Sanofi Enhances Oncology Therapeutics Portfolio With Acquisition Of Amunix And Innovative Pro-Xten Technology

In February 2022, Sanofi S.A., a France-based multinational pharmaceutical and healthcare company, acquired Amunix for an undisclosed amount. This acquisition provides access to Amunix Pro-XTEN, XPAT, and XPAC technology to deliver conditionally activated biologics of the next generation. The technology platform supports Sanofi's efforts to accelerate and expand its contributions to cutting-edge therapies for oncology patients, with about 20 compounds presently in development. It is a perfect addition to Sanofi's existing R&D platforms. Amunix is a US-based immuno-oncology company intended to discover, design, and develop novel biologics, proteins, and peptide therapeutics.

Regional Analysis For The Global Therapeutic BCG Vaccines Market

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Therapeutic BCG Vaccines Market?

The therapeutic BCG vaccines market consists of sales of vectors, peptides, proteins, DNA, and dendritic cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Therapeutic BCG Vaccines Industry?

The therapeutic bcg vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic bcg vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Therapeutic BCG Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $59.09 billion
Revenue Forecast In 2034 $75.46 billion
Growth Rate CAGR of 6.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users Subsegments: 1) By Therapy BCG: Intravesical BCG, Injectable BCG
2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Therapeutic BCG Vaccines Market Characteristics

3. Therapeutic BCG Vaccines Market Trends And Strategies

4. Therapeutic BCG Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Therapeutic BCG Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Therapeutic BCG Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Therapeutic BCG Vaccines Market Growth Rate Analysis

5.4. Global Therapeutic BCG Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Therapeutic BCG Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Therapeutic BCG Vaccines Total Addressable Market (TAM)

6. Therapeutic BCG Vaccines Market Segmentation

6.1. Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Therapy BCG

Immune BCG

6.2. Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatrics

Adults

6.3. Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.4. Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Therapy BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravesical BCG

Injectable BCG

6.5. Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Immune BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

BCG For Immune Enhancement

BCG For Allergy Treatment

7. Therapeutic BCG Vaccines Market Regional And Country Analysis

7.1. Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Therapeutic BCG Vaccines Market

8.1. Asia-Pacific Therapeutic BCG Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Therapeutic BCG Vaccines Market

9.1. China Therapeutic BCG Vaccines Market Overview

9.2. China Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Therapeutic BCG Vaccines Market

10.1. India Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Therapeutic BCG Vaccines Market

11.1. Japan Therapeutic BCG Vaccines Market Overview

11.2. Japan Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Therapeutic BCG Vaccines Market

12.1. Australia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Therapeutic BCG Vaccines Market

13.1. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Therapeutic BCG Vaccines Market

14.1. South Korea Therapeutic BCG Vaccines Market Overview

14.2. South Korea Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Therapeutic BCG Vaccines Market

15.1. Western Europe Therapeutic BCG Vaccines Market Overview

15.2. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Therapeutic BCG Vaccines Market

16.1. UK Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Therapeutic BCG Vaccines Market

17.1. Germany Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Therapeutic BCG Vaccines Market

18.1. France Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Therapeutic BCG Vaccines Market

19.1. Italy Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Therapeutic BCG Vaccines Market

20.1. Spain Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Therapeutic BCG Vaccines Market

21.1. Eastern Europe Therapeutic BCG Vaccines Market Overview

21.2. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Therapeutic BCG Vaccines Market

22.1. Russia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Therapeutic BCG Vaccines Market

23.1. North America Therapeutic BCG Vaccines Market Overview

23.2. North America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Therapeutic BCG Vaccines Market

24.1. USA Therapeutic BCG Vaccines Market Overview

24.2. USA Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Therapeutic BCG Vaccines Market

25.1. Canada Therapeutic BCG Vaccines Market Overview

25.2. Canada Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Therapeutic BCG Vaccines Market

26.1. South America Therapeutic BCG Vaccines Market Overview

26.2. South America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Therapeutic BCG Vaccines Market

27.1. Brazil Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Therapeutic BCG Vaccines Market

28.1. Middle East Therapeutic BCG Vaccines Market Overview

28.2. Middle East Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Therapeutic BCG Vaccines Market

29.1. Africa Therapeutic BCG Vaccines Market Overview

29.2. Africa Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Therapeutic BCG Vaccines Market Competitive Landscape And Company Profiles

30.1. Therapeutic BCG Vaccines Market Competitive Landscape

30.2. Therapeutic BCG Vaccines Market Company Profiles

30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Japan BCG Laboratory Overview, Products and Services, Strategy and Financial Analysis

30.2.4. China National Biotec Group Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Therapeutic BCG Vaccines Market Other Major And Innovative Companies

31.1. InterVax Ltd.

31.2. GreenSignal Bio Pharma Limited

31.3. Statens Serum Institute

31.4. AJ Vaccines

31.5. Bul Bio-National Center of Infectious and Parasitic Diseases Ltd

31.6. Biomed Lublin S.A.

31.7. Microgen

31.8. Taj Pharma Ltd.

31.9. PT Bio Farma

31.10. Torlak Institute of Virology

31.11. Bacille Bilie Calmette-Guerin Laboratory

31.12. China Biotechnology Co Ltd.

31.13. Bharat Biotech International Ltd.

31.14. Biological E. Limited

31.15. Shanghai Institute of Biological Products Co. Ltd.

32. Global Therapeutic BCG Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Therapeutic BCG Vaccines Market

34. Recent Developments In The Therapeutic BCG Vaccines Market

35. Therapeutic BCG Vaccines Market High Potential Countries, Segments and Strategies

35.1 Therapeutic BCG Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Therapeutic BCG Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Therapeutic BCG Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Therapy BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Immune BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Merck & Co Inc. Financial Performance
  • Table 77: Sanofi Pasteur Financial Performance
  • Table 78: Japan BCG Laboratory Financial Performance
  • Table 79: China National Biotec Group Financial Performance
  • Table 80: Serum Institute of India Pvt. Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Therapy BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Immune BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Merck & Co Inc. Financial Performance
  • Figure 77: Sanofi Pasteur Financial Performance
  • Figure 78: Japan BCG Laboratory Financial Performance
  • Figure 79: China National Biotec Group Financial Performance
  • Figure 80: Serum Institute of India Pvt. Ltd. Financial Performance

Antiobesity Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Antiobesity Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Antiobesity Market Landscape: Innovative Advancements In The Anti-Parkinson Drugs Market

Read More About Emerging Trends Redefining the Antiobesity Market Landscape: Innovative Advancements In The Anti-Parkinson Drugs Market

Top Trends Driving Innovation and Change in the Anti-Thyroid Drugs Market: Raising Awareness And Promoting Thyroid Health In The Anti-Thyroid Drug Market

Read More About Top Trends Driving Innovation and Change in the Anti-Thyroid Drugs Market: Raising Awareness And Promoting Thyroid Health In The Anti-Thyroid Drug Market

Market Trends Influencing Strategic Decisions in the Antivirals Industry: Innovative Oral Antiviral Treatments Enhancing Patient Compliance And Accessibility In The Fight Against Viral Infections

Read More About Market Trends Influencing Strategic Decisions in the Antivirals Industry: Innovative Oral Antiviral Treatments Enhancing Patient Compliance And Accessibility In The Fight Against Viral Infections

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

View Report

UV Disinfection Equipment Global Market Report 2025 – By Component( UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating( Low, Medium, High ), By Application( Water Treatment, Was...

View Report

UV Disinfection Equipment Global Market Report 2025 – By Component( UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating( Low, Medium, High ), By Application( Water Treatment, Was...

View Report

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, C...

View Report

Refrigerated Transport Global Market Report 2025 – By Transport Type (Refrigerated Road Transport, Refrigerated Medium & Heavy Commercial Vehicles (MHCV), Refrigerated Light Commercial Vehicles (LCV), Refrigerated Heavy ...

View Report

Reed Switch Device Global Market Report 2025 – By Product Type (Normally Open (A-Type), Normally Closed (B-Type), Changeover (C-Type) ), By Distribution Channel (Direct Sales, Distributor ), By Application (Magnetic Sens...

View Report

Automatic Effluent Samplers Global Market Report 2025 – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel ( Direct Sales, Distributors, Online Sales), By Application (Industrial Wastewater...

View Report

Frequently Asked Questions

Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime. For further insights on this market, request a sample here

The market major growth driver - Fighting Tuberculosis Surging Global Cases Propel Growth In The Therapeutic Bcg Vaccine Market. For further insights on this market, request a sample here

The therapeutic bcg vaccines market size has grown steadily in recent years. It will grow from $56.47 billion in 2024 to $59.09 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains. The therapeutic bcg vaccines market size is expected to see strong growth in the next few years. It will grow to " $75.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches. For further insights on this market, request a sample here

The therapeutic bcg vaccines market covered in this report is segmented –
1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users Subsegments:
1) By Therapy BCG: Intravesical BCG, Injectable BCG
2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment For further insights on this market, request a sample here

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan . For further insights on this market, request a sample here.

Major trends in this market include ImmunityBio And Serum Institute Of India Strategic Partnership To Advance Therapeutic Bcg Vaccine Development. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Therapeutic BCG Vaccines Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon